免疫系统
前列腺癌
增生
转录组
恶性肿瘤
癌症研究
前列腺
医学
生物
脂质运载蛋白
免疫学
癌症
肿瘤微环境
恶性转化
细胞
免疫疗法
良性前列腺增生(BPH)
CD8型
先天免疫系统
表型
炎症
PCA3系列
细胞因子
作者
Yuanyuan Luo,Haitao Zhong,Tongrui Shang,Bin Hu,Dongbo Yuan,Xueyuan Jia,Ruichong Lin,Zehua Wang,Yinyi Fang,Guohua Zhu,Jukun Song,Zhangcheng Liu,Bo Yan,Fa Sun,Zhenyu Jia,Y P Yu,Luhui Mao,Hai Huang,Jianguo Zhu
出处
期刊:MedComm
[Wiley]
日期:2026-05-23
卷期号:7 (6): e70760-e70760
摘要
Prostate cancer (PCa) is frequently accompanied by benign prostatic hyperplasia (BPH), highlighting the need to reassess their correlation in tumor risk, malignant progression, and immune status to improve the early diagnosis and treatment of PCa. In this study, single-cell RNA sequencing and spatial transcriptomics were used to analyze the potential association between normal, BPH, and PCa tissues. Our study revealed a continuous transformation map of luminal epithelial cells from hyperplasia to malignancy in BPH and PCa, accompanied by a persistently suppressive immune microenvironment. In the lesion nodules, T cells showed a high degree of infiltration yet showed activation retardation and functional exhaustion. Macrophages were also significantly infiltrated, exhibiting significant M2 polarization characteristics, and inflammatory signaling pathways related to immune escape were activated. Natural killer (NK) cells and B cells were partially activated, yet the low abundance of NK cells and B cells resulted in functional limitations. Our results revealed the dynamic changes of the immune landscape during the occurrence and progression of PCa. Our classification and prognostic models provide a theoretical basis for immunomodulatory and personalized therapies and provide new tools for the early diagnosis and intervention of PCa.
科研通智能强力驱动
Strongly Powered by AbleSci AI